Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10 mg Prednisone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 44
25 mg Prednisone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 44
35-Aminosalicylic acid(5-ASA) and/or Prednisone3件: Aminosalicylic acid,
Mesalazine,
Prednisone		3件: D00162 ,
D00377 ,
D00473 (Name: Prednisone)		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97
4Adalimumab, plus prednisone2件: Adalimumab,
Prednisone		2件: D00473 (Name: Prednisone),
D02597 		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
5Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil4件: Methylprednisolone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		11件: D00407 ,
D00473 (Name: Prednisone),
D00751 ,
D00752 ,
D00979 ,
D05000 ,
D05001 ,
D05002 ,
D05094 ,
D05095 ,
D05096 		3件: IMPDH1,
IMPDH2,
NR3C1 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬1件: 49
6Azathioprine/prednisone2件: Azathioprine,
Prednisone		3件: D00238 ,
D00473 (Name: Prednisone),
D03033 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 85
7Behavioral: Duchenne Muscular Dystrophy group with Prednisone/Predisolone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
8Capsule di prednisone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
9Chinese Herb Prescription Granule plus prednisone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
10Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)6件: Acetate,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		20件: D00088 ,
D00292 ,
D00472 ,
D00473 (Name: Prednisone),
D00973 ,
D00975 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D01998 ,
D02156 ,
D02174 ,
D02591 ,
D02592 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
11Corticosteroids (prednisone or prednisolone)2件: Prednisolone,
Prednisone		9件: D00472 ,
D00473 (Name: Prednisone),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 49
12Cyclophosphamide, Azathioprine,prednisone,methylprednisolone4件: Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		11件: D00238 ,
D00287 ,
D00407 ,
D00473 (Name: Prednisone),
D00751 ,
D00979 ,
D03033 ,
D05000 ,
D05001 ,
D05002 ,
D07760 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45
13Cyclophosphamide-prednisone-azathioprine3件: Azathioprine,
Cyclophosphamide,
Prednisone		5件: D00238 ,
D00287 ,
D00473 (Name: Prednisone),
D03033 ,
D07760 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 49
14Glucocorticoid (prednisone or prednisolone)2件: Prednisolone,
Prednisone		9件: D00472 ,
D00473 (Name: Prednisone),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84
15Granulocyte-colony stimulating factor (G-CSF) and prednisone2件: Filgrastim,
Prednisone		2件: D00473 (Name: Prednisone),
D03235 		2件: CSF3R,
NR3C1 💬		6件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 13
16Hormone (prednisone)1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
17Hydroxychloroquine + low-dose prednisone2件: Hydroxychloroquine,
Prednisone		2件: D00473 (Name: Prednisone),
D08050 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84
18Hydroxychloroquine + Prednisone2件: Hydroxychloroquine,
Prednisone		2件: D00473 (Name: Prednisone),
D08050 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84
19IR Prednisone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
20Leflunomide 20 mg+prednisone 0.5mg/kg/d2件: Leflunomide,
Prednisone		2件: D00473 (Name: Prednisone),
D00749 		2件: DHODH,
NR3C1 💬		4件: Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬1件: 66
21Methylprednisolone (MP) or prednisone (pred)2件: Methylprednisolone,
Prednisone		7件: D00407 ,
D00473 (Name: Prednisone),
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
22MR Prednisone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
23Mycophenolate mofetil plus lower dose of Prednisone3件: Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		5件: D00473 (Name: Prednisone),
D00752 ,
D05094 ,
D05095 ,
D05096 		3件: IMPDH1,
IMPDH2,
NR3C1 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬1件: 66
24Oral prednisone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 251
25Oral Prednisone 5mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 49
26Other: prednisone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
27Over encapsulated prednisone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
28Prednisolone/Prednisone2件: Prednisolone,
Prednisone		9件: D00472 ,
D00473 (Name: Prednisone),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 49
29Prednisone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331
30Prednisone (and methylprednisolone)2件: Methylprednisolone,
Prednisone		7件: D00407 ,
D00473 (Name: Prednisone),
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 43
31Prednisone + Inhibace/Cozaar1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
32Prednisone - Azathioprine2件: Azathioprine,
Prednisone		3件: D00238 ,
D00473 (Name: Prednisone),
D03033 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 11
33Prednisone 0,5 mg/kg orally on alternate days1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222
34Prednisone 1 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
35Prednisone 15 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
36Prednisone 2 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
37Prednisone 3 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
38Prednisone 4 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
39Prednisone 5 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 46, 66
40Prednisone 5 mg tablets1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
41Prednisone 7.5 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
42Prednisone Acetate3件: Acetate,
Prednisone,
Prednisone acetate		2件: D00473 (Name: Prednisone),
D08416 (Name: Prednisone acetate)		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬4件: 40, 46, 49, 224
43Prednisone Acetate Tablets3件: Acetate,
Prednisone,
Prednisone acetate		2件: D00473 (Name: Prednisone),
D08416 (Name: Prednisone acetate)		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 224
44Prednisone alone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 11, 66
45Prednisone and Belimumab2件: Belimumab,
Prednisone		2件: D00473 (Name: Prednisone),
D03068 		2件: NR3C1,
TNFSF13B 💬		5件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬1件: 300
46Prednisone and cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: D00287 ,
D00473 (Name: Prednisone),
D07760 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
47Prednisone and Mycophenolate mofetil3件: Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		5件: D00473 (Name: Prednisone),
D00752 ,
D05094 ,
D05095 ,
D05096 		3件: IMPDH1,
IMPDH2,
NR3C1 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬1件: 300
48Prednisone and ustekinumab treatment2件: Prednisone,
Ustekinumab		2件: D00473 (Name: Prednisone),
D09214 		4件: IL12A,
IL12B,
IL23A,
NR3C1 💬		29件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 41
49PREDNISONE ARROW 20mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
50PREDNISONE ARROW 5 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
51Prednisone Capsule1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
52Prednisone Capsules1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
53Prednisone discontinuation1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 49
54PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 300
55Prednisone in full dose1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
56Prednisone or Prednisolone2件: Prednisolone,
Prednisone		9件: D00472 ,
D00473 (Name: Prednisone),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 66, 84
57Prednisone plus cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: D00287 ,
D00473 (Name: Prednisone),
D07760 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
58Prednisone plus exercise1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
59PredniSONE Tablets USP, 1 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 41, 46
60PredniSONE Tablets USP, 10 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
61PredniSONE Tablets USP, 1mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
62PredniSONE Tablets USP, 2.5 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
63PredniSONE Tablets USP, 2.5mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
64PredniSONE Tablets USP, 20mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
65PredniSONE Tablets USP, 5 mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 41, 46
66PredniSONE Tablets USP, 5mg1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
67PredniSONE Tablets, USP1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 41, 43, 44
68Prednisone therapy and pharmacokinetic1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
69Prednisone treatment1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
70Prednisone with daily edasalonexent2件: Edasalonexent,
Prednisone		2件: D00473 (Name: Prednisone),
D12181 		2件: NR3C1,
RELA 💬		77件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬1件: 113
71Prednisone, ciclosporin and mycophenolate mofetil4件: Cyclosporine,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		6件: D00184 ,
D00473 (Name: Prednisone),
D00752 ,
D05094 ,
D05095 ,
D05096 		8件: IMPDH1,
IMPDH2,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222
72Prednisone, cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: D00287 ,
D00473 (Name: Prednisone),
D07760 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 40
73Prednisone, FK506, MMF1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222
74Prednisone, low dose rituximab2件: Prednisone,
Rituximab		2件: D00473 (Name: Prednisone),
D02994 		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 61
75Prednisone, methylprednisolone,cyclophosphamides2件: Methylprednisolone,
Prednisone		7件: D00407 ,
D00473 (Name: Prednisone),
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45
76Prednisone/Prednisolone2件: Prednisolone,
Prednisone		9件: D00472 ,
D00473 (Name: Prednisone),
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 35
77Pyridostigmine, Prednisone, Tacrolimus3件: Prednisone,
Pyridostigmine,
Tacrolimus		4件: D00107 ,
D00473 (Name: Prednisone),
D00487 ,
D08556 		7件: ACHE,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		36件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cholinergic synapse, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Glycerophospholipid metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 11
78RAYOS (delayed-release prednisone)1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
79Sotatercept with prednisone boost2件: Prednisone,
Sotatercept		2件: D00473 (Name: Prednisone),
D09670 		2件: ACVR2A,
NR3C1 💬		5件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 284
80Tacrolimus combined with prednisone2件: Prednisone,
Tacrolimus		3件: D00107 ,
D00473 (Name: Prednisone),
D08556 		6件: NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222
81Thalidomide, cyclophosphamide and prednisone3件: Cyclophosphamide,
Prednisone,
Thalidomide		4件: D00287 ,
D00473 (Name: Prednisone),
D00754 ,
D07760 		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 331
82Thymectomy plus prednisone1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 11
83Treatment systemic therapy (prednisone)1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 162
84Treatment with systemic therapy (prednisone)1件: Prednisone1件: D00473 (Name: Prednisone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 162
85Vinblastine, vincristine, prednisone, daunorubicin4件: Daunorubicin,
Prednisone,
Vinblastine,
Vincristine		7件: D00473 (Name: Prednisone),
D01068 ,
D01264 ,
D02197 ,
D07776 ,
D08675 ,
D08679 		12件: NR3C1,
TOP2A,
TOP2B,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Platinum drug resistance, Prion disease, Salmonella infection 💬1件: 65